This project will establish a commercially viable, regenerative biomaterial-based method for effective, reduced-cost and clinically feasible culture of immune cells for immune cell therapies. Argan Biomedical Technologies inc, partnering with the Sefton lab at UofT, has developed technology that uses regenerative synthetic biomaterials to reduce the use of expensive and otherwise problematic biological components used […]
Read More